Tag: Curevac
CureVac reports promising results from COVID-19 vaccine trials conducted in collaboration with GSK
© Reuters. FRANKFURT – CureVac recently reported encouraging results from its latest COVID-19 vaccine trials, conducted in partnership with GSK. Preliminary data indicate that the vaccines, comprising a monovalent and…
Leaning on Biontech: Curevac has suffered a setback in the patent dispute
Bear with Biontech Curevac has suffered a setback in the patent dispute December 19, 2023, 3:45 p.m The biotech company Curevac is losing out in the patent dispute with its…
Zoff over patents in court: Curevac demands a share in Biontech billions
Zoff about patents in court Curevac demands a share in Biontech billions 08/15/2023 5:29 p.m It’s about a lot of money: The vaccine developer Curevac accuses its successful competitor Biontech…
AI dreams fuel Microsoft: Wall Street takes off after Powell statement
AI dreams inspire Microsoft Wall Street takes off after Powell statement 02/07/2023, 10:45 p.m Reading coffee grounds on the US stock exchanges: Fed boss Powell announces that inflation will fall…
Positive study data: ray of hope for Curevac – share price picks up again
Positive study data Ray of hope for Curevac – share price picks up again 1/9/2023 4:43 p.m Curevac is repositioning itself at the top. The new combined vaccination against influenza…
Allegation: Patent infringement: Curevac files a lawsuit against Biontech
Allegation: Patent infringement Curevac files a lawsuit against Biontech 07/05/2022, 3:38 p.m Curevac was one of the great hopes of developing a corona vaccine, but was not successful. The Tübingen-based…
Curevac is suing Biontech for patent infringement
EInst they were considered the two German vaccine hopes, now there is a legal dispute: Curevac accuses Biontech of patent infringements and has filed a lawsuit against the Mainz mRNA…
Vaccine manufacturer Curevac is suing Biontech
Vaccine manufacturer Curevac is suing Biontech Curevac is seeking compensation for its research into mRNA technology. Andrea Ronchini / www.imago-images.de no. The German vaccine manufacturer Curevac is suing its competitor…
Second attempt: Curevac is pushing ahead with corona vaccine plans
Second attempt Curevac is pushing ahead with corona vaccine plans 02/12/2022, 2:11 p.m In the first attempt, Curevac failed with the development of a corona vaccine. Now the Tübingen-based company…
Especially against the Omikron variant: Curevac is researching a vaccine update
Tuesday, January 04, 2022 Especially against the Omikron variant Curevac is researching a vaccine update The biotech company Curevac is making another attempt: After the former hope has withdrawn his…
Novartis Germany boss Lang: “There are hidden pandemics”
Friday October 22, 2021 Novartis Germany boss Lang “There are hidden pandemics” The corona crisis is changing the pharmaceutical landscape: Small players like Biontech have developed more successful vaccines than…
Covid-19: CureVac abandons its vaccine candidate
The announcement seemed inevitable. The German laboratory CureVac decided, Tuesday, October 12, to put away its first candidate-messenger RNA vaccine against Covid-19, on which the company had been working across…